We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+7%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$263M
AUM Growth
-$4.42M
Cap. Flow
-$7.23M
Cap. Flow %
-2.75%
Top 10 Hldgs %
45.01%
Holding
265
New
72
Increased
63
Reduced
52
Closed
76

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$3.73M
2
MCD icon
McDonald's
MCD
+$3.07M
3
ADI icon
Analog Devices
ADI
+$2.85M
4
WFC icon
Wells Fargo
WFC
+$2.74M
5
MS icon
Morgan Stanley
MS
+$2.6M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$3.81M
2
BAC icon
Bank of America
BAC
+$2.79M
3
VZ icon
Verizon
VZ
+$2.35M
4
PG icon
Procter & Gamble
PG
+$2.07M
5
NEE icon
NextEra Energy
NEE
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Financials 14.68%
3 Healthcare 9.28%
4 Consumer Discretionary 7.05%
5 Industrials 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRG icon
176
PROG Holdings
PRG
$1.66B
$392K 0.15%
9,284
-52
-0.6% -$2.4K
BLDR icon
177
Builders FirstSource
BLDR
$8.08B
$391K 0.15%
2,739
+187
+7% +$33.1K
AMRC icon
178
Ameresco
AMRC
$1.37B
$382K 0.15%
+16,287
New +$470K
KBH icon
179
KB Home
KBH
$3.54B
$356K 0.14%
5,423
+385
+8% +$30K
PSX icon
180
Phillips 66
PSX
$89.5B
$352K 0.13%
3,089
+200
+7% +$25.4K
MCO icon
181
Moody's
MCO
$82.5B
$351K 0.13%
+741
New +$354K
SPGI icon
182
S&P Global
SPGI
$120B
$341K 0.13%
+685
New +$348K
CRUS icon
183
Cirrus Logic
CRUS
$6.11B
$335K 0.13%
3,366
+51
+2% +$5.6K
REGN icon
184
Regeneron Pharmaceuticals
REGN
$82.1B
$313K 0.12%
439
-191
-30% -$160K
SMCI icon
185
Super Micro Computer
SMCI
$20.4B
$306K 0.12%
+10,023
New +$364K
TRV icon
186
Travelers Companies
TRV
$78.3B
$213K 0.08%
885
-200
-18% -$49.9K
QQQ icon
187
Invesco QQQ Trust
QQQ
$478B
$206K 0.08%
+403
New +$204K
SPY icon
188
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$164K 0.06%
280
IWM icon
189
CALL
iShares Russell 2000 ETF
IWM
$81.8B
$66.3K 0.03%
300
ADUS icon
190
Addus HomeCare
ADUS
$2.18B
-2,949
Closed -$392K
ANAB icon
191
AnaptysBio
ANAB
$1.71B
-12,160
Closed -$407K
AOSL icon
192
Alpha and Omega Semiconductor
AOSL
$1.04B
-10,994
Closed -$408K
ARDX icon
193
Ardelyx
ARDX
$1.02B
-74,137
Closed -$511K
BASE
194
DELISTED
Couchbase
BASE
-27,306
Closed -$440K
BCRX icon
195
BioCryst Pharmaceuticals
BCRX
$2.64B
-58,898
Closed -$448K
BFH icon
196
Bread Financial
BFH
$4.36B
-8,389
Closed -$399K
BKU icon
197
Bankunited
BKU
$3.35B
-12,156
Closed -$443K
BLFS icon
198
BioLife Solutions
BLFS
$1.7B
-18,653
Closed -$467K
BMRN icon
199
BioMarin Pharmaceuticals
BMRN
$13.5B
-6,618
Closed -$465K
BURL icon
200
Burlington
BURL
$22.6B
-2,899
Closed -$764K

Similar funds

Alpha DNA Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Alpha DNA Investment Management held 265 positions worth $263M, down 1.7% from $267M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Alpha DNA Investment Management's Q4 2024 filing shows 72 new, 63 increased, 52 reduced and 76 closed positions. Its largest new stake was Palo Alto Networks: 6,205 shares worth $1.13M. The largest sale was Walmart Inc, an estimated $3.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Alpha DNA Investment Management's largest Q4 2024 buy was Palo Alto Networks: 6,205 shares worth $1.13M.
  • Alpha DNA Investment Management added most to Accenture in Q4 2024, an estimated $3.73M increase.
  • Alpha DNA Investment Management's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $3.81M.
  • Alpha DNA Investment Management fully exited Verizon in Q4 2024, selling an estimated $2.35M.
  • Alpha DNA Investment Management's ten largest holdings make up 45% of its $263M portfolio in Q4 2024.
  • Alpha DNA Investment Management opened 72 new positions and closed 76 in Q4 2024.
  • Alpha DNA Investment Management's portfolio value fell 1.7% quarter-over-quarter to $263M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.